A study found that a blood test detecting ctDNA after surgery more accurately predicts recurrence and survival in patients with stage 3 colon cancer.
Researchers at The Institute of Cancer Research have found a dual genetic test is more accurate than the traditional approach in identifying multiple myeloma patients who may be at an elevated risk of ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company and research collaborators at Mayo Clinic and the Alliance for Clinical Trials in Oncology today announced publication of the ...
LAS VEGAS, Nev. (FOX5) - The VA Medical Center in North Las Vegas says they are the first hospital in the region to offer a new kind of testing. The goal is to look at a veteran patient’s DNA profile ...
A single drop of blood on a broken window could soon lead to answers much faster in the Lowcountry.
With only five exonerations, lawmakers weigh bills that would update Delaware's DNA evidence practices, aligning the state ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results